• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CALCIUM CHLORIDE 10%; SALINE, VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CALCIUM CHLORIDE 10%; SALINE, VASCULAR ACCESS FLUSH Back to Search Results
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Description
While our iv tech was compounding, tech pulled what she thought was calcium chloride 10% syringe for use in a iv piggyback.She thought she was pulling calcium chloride 10% 1000mg/10ml push syringe (ndc 64253-900-30 medefil mfg) to add to 0.9 ns 50ml bag.She was about to scan item in epic before injection and she found she had pulled heparin lock flush 500 usp/5ml (ndc 64253-333-35 medefil mfg.) these 2 medications look identical.Similar packaging and coloring.This never reached patient.Found prior to scan in epic/dispense prep.(b)(6).Submission id: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CALCIUM CHLORIDE 10%
Type of Device
SALINE, VASCULAR ACCESS FLUSH
MDR Report Key12883981
MDR Text Key281584465
Report NumberMW5105646
Device Sequence Number1
Product Code NZW
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 06/09/2021
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/26/2021
Patient Sequence Number1
Treatment
EPIC
-
-